HAVCR2 and hypophysitis: Consistent data was seen in a patient affected by mesothelioma who developed fatal neuroendocrine toxicity (insulin-dependent diabetes, hypophysitis, and a myasthenia-like syndrome) while he was on treatment with a dual mAb blocking PD1 and TIM3 [64].